Utah Medical Products, Inc.
UTMD Healthcare Medical Instruments & Supplies
Utah Medical Products, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, down 5.83% from fiscal 2024. In the quarter to June 2026, revenue fell 14.3%, EPS fell 10.6% and free cash flow fell 55.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years.
Follow UTMD
Utah Medical Products, Inc. (UTMD) P/E ratio
As of 16 October 2026, Utah Medical Products, Inc. (UTMD) trades at a P/E ratio of 22.7×. Over the past ten years it has ranged from 13.7× (April 2025) to 47.7× (June 2018); the current reading is higher than 73% of that period. That is below the Medical Instruments & Supplies industry median of 33.8× and in line with the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 16.1× | 3.33% |
| FY2024 | 15.6× | (14.81%) |
| FY2023 | 18.3× | (15.73%) |
| FY2022 | 21.7× | (12.21%) |
| FY2021 | 24.7× | (14.18%) |
| FY2020 | 28.8× | 5.06% |
| FY2019 | 27.4× | 63.17% |
| FY2018 | 16.8× | (51.53%) |
| FY2017 | 34.6× | 55.68% |
| FY2016 | 22.2× | 19.31% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 21.0× | 14.67% |
| Mar 2026 | 18.3× | 14.05% |
| Dec 2025 | 16.1× | (9.60%) |
| Sep 2025 | 17.8× | 16.88% |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SMTI Sanara MedTech Inc. compare | n/m |
| KRMD KORU Medical Systems, Inc. compare | n/m |
| NYXH Nyxoah SA compare | n/m |
| OSUR OraSure Technologies, Inc. compare | n/m |
| EMBC Embecta Corp. compare | 4.2× |
| PDEX Pro-Dex, Inc. compare | 13.8× |
| UTMD Utah Medical Products, Inc. | 22.7× |
| NNNN Anbio Biotechnology compare | — |
| ZJYL Jin Medical International Ltd. compare | — |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)